Trials / Completed
CompletedNCT01159613
Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
Do Low HDL Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Ziv Hospital · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The working hypothesis is that the low HDL serum level predict favorable response to anti viral treatment in chronic HCV (genotype 1) viral infection. This might be used to improve the rate of sustained virologic response.
Detailed description
Lipoproteins are closely connected to the process of hepatitis C virus (HCV) infection. Metabolic syndrome predicts negative treatment outcome in HCV infection. Aim: to assess the association between lipids components of the metabolic syndrome and sustained viral response (SVR).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Responders | Responders |
| OTHER | Non Responders | Non Responders |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2008-10-01
- Completion
- 2009-01-01
- First posted
- 2010-07-09
- Last updated
- 2010-07-09
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01159613. Inclusion in this directory is not an endorsement.